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Abstract
Introduction: Over the last five years, the American Association for the Surgery of Trauma 
(AAST) has developed grading scales for Emergency General Surgery (EGS) diseases. In a prior 
validation study using diverticulitis, the grading scales were predictive of complications and length 
of stay. As EGS encompasses diverse diseases, the purpose of this study was to validate the 
grading scale concept against a different disease process with a higher associated mortality. We 
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hypothesized that the grading scale would be predictive of complications, length of stay and 
mortality in skin and soft tissue infections (STI).
Methods: This multi-institutional trial encompassed 12 centers. Data collected included 
demographic variables, disease characteristics and outcomes such as mortality, overall 
complications, hospital and ICU length of stay. The EGS scale for STI was used to grade each 
infection and two surgeons graded each case to evaluate inter-rater reliability.
Results: 1170 patients were included in this study. Inter-rater reliability was moderate (kappa 
coefficient 0.472-0.642, with 64-76% agreement). Higher grades (IV and V) corresponded to 
significantly higher LRINEC scores when compared with lower EGS grades. Patients with grade 
IV and V STI had significantly increased odds of all complications, as well as ICU and overall 
length of stay. These associations remained significant in logistic regression controlling for age, 
gender, comorbidities, mental status and hospital-level volume. Grade V disease was significantly 
associated with mortality as well.
Conclusion: This validation effort demonstrates that Grade IV and V STI are significantly 
predictive of complications, hospital length of stay and mortality. Though predictive ability does 
not improve linearly with STI grade, this is consistent with the clinical disease process, in which 
lower grades represent cellulitis and abscess and higher grades are invasive infections. This second 
validation study confirms the EGS grading scale as predictive, and easily used, in disparate disease 
processes.
Study Type : Prognostic/Epidemiologic retrospective multicenter trial
Level of Evidence : III
Keywords
EGS grading scales; skin and soft tissue infections; necrotizing fasciitis; LRINEC score
Introduction
Over the last five years, the American Association for the Surgery of Trauma (AAST) has 
developed grading scales for the most prevalent emergency general surgery (EGS) disease 
processes. These grading scales were inspired by the original Organ Injury Severity scales 
developed by the AAST in the mid-1980’s.1-3 Formulated from expert consensus opinion of 
AAST committee members and highly structured in format, the EGS scales rate the 
anatomic severity of disease processes from mild to severe, incorporating aspects of clinical 
presentation, radiographic findings as well as operative and pathologic data when available. 
The purpose of these scales was not only to prognosticate outcomes but to also create a 
standardized language used to categorize diseases as patients moved through an increasingly 
regionalized system of care. Additionally, the grading scales provide an important reference 
when constructing EGS data registries and conducting research. 4
The current EGS grading scales encompass twenty of the most common disease processes – 
including infectious, hemorrhagic and ulcerative diseases. Validation of these AAST EGS 
scales began by studying acute colonic diverticulitis, as it represented a common and well-
understood disease process. In both an initial pilot study and a subsequent prospective, 
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observational multicenter study, the grading scale demonstrated significant associations 
between higher-grade disease and outcomes such as the need for operative intervention, 
subsequent complications, length of stay, 30-day readmission rates and mortality. The 
studies also demonstrated good inter-rater reliability.5-6
The disease processes addressed by the EGS grading scales represent quite disparate 
physiologic and pathologic processes however. The prognostic ability of the grading scale 
for acute colonic diverticulitis, though reassuring, does not necessarily translate to other 
diseases, such as acute bowel ischemia, breast infections or hernias. Therefore, the purpose 
of this study was to perform a follow-up multicenter validation study focusing on a different 
disease process with more profound associated physiologic derangement. Soft tissue 
infections (STI) were chosen due to the high incidence of operative interventions, significant 
physiologic insult to the patient and significant mortality associated with more severe grades 
of disease, as represented by necrotizing infections. Our hypothesis was that increasing 
disease grades would be associated with longer ICU and hospital length of stay, increased 
complication rates and increased mortality. We also hypothesized that inter-rater reliability 
would remain high despite applying a standardized scale to a different disease.
Methods
We conducted a multicenter retrospective cohort study as a project under the auspices of the 
AAST Patient Assessment Committee. The investigators at each participating center 
obtained local Institutional Review Board approval.
Study Design and Population
Most STIs involve cellulitis or abscess, rather than a necrotizing infection, and thus are 
concentrated in the low grades of the AAST grading scale. Therefore, a stratified sampling 
approach was used to enrich the study sample with uncommon, more severe cases. This 
allowed evaluation of the performance of the grading classification relatively equally across 
the spectrum of disease severity.
Investigators at each center submitted a de-identified list of all hospitalizations (an 
identification key with discharge diagnoses) from January 1, 2013 through August 31, 2015, 
with at least one International Classification of Diseases, 9th Revision, Clinical Modification 
(ICD-9-CM) diagnosis code corresponding to an STI (Supplemental Digital Content). [For 
one Canadian center, we translated the relevant ICD-9-CM diagnosis codes to those in the 
International Classification of Diseases, 10th Revision, Canada (ICD-10-CA).] One 
investigator categorized records involving an STI into seven strata (Supplemental Digital 
Content), then randomly selected records within each stratum to achieve targeted 
proportions of records per stratum and a total sample of 100 records/center. If some selected 
records were subsequently found to be ineligible, additional records were selected according 
to the same overall sampling scheme to achieve 100 eligible records/center (Figure 1).
Investigators at each center reviewed selected records. Records were excluded if the patient 
was pregnant, had an advanced directive limiting life-sustaining care, underwent an 
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operation for the index STI prior to the hospitalization of interest or, based on review of the 
full medical record, were found not to have had an STI.
Data Collection
From September 2016 to December 2017, investigators at each center collected information 
for eligible hospitalizations on demographic characteristics, diagnoses and procedures 
occurring during the hospitalization, components of the Sequential Organ Failure 
Assessment (SOFA) and the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) 
scores within the first 24 hours after presentation. Additional data collected included 
vasopressor requirements, AAST grade of STI (based separately on clinical, radiologic, 
operative, and pathologic criteria) (Figure 2), antibiotic therapies and complications that 
occurred during the index hospitalization (Appendix 1).4 Investigators entered data in a 
standard format via the AAST Multi-institutional Trials website.
Exposure and Outcomes
The exposure, the AAST grade of STI, was defined as the maximum of the assignable 
grades determined from the clinical, radiologic, operative, or pathologic criteria. Two 
investigators at each center assigned grades independently. The primary grader entries were 
utilized in the main analysis.
Complications were the primary outcome in this study. Complications were compiled in two 
ways for this study. Each center was asked to record incidence of myocardial infarction, 
stroke, urinary tract infection and pneumonia as separate data points. Secondly, abstractors 
were also allowed to write-in pertinent complications under an ‘other complication’ variable. 
The ‘other complications’ were used to create a composite complication variable for the 
purposes of analysis. Disorders included in the composite variable are listed in Appendix 1. 
Additional outcomes included ICU and hospital length of stay, 30-day readmissions and 
mortality.
Analysis
Frequency distributions of categorical variables, mean (±standard deviation), and median 
(interquartile range) for normally and non-normally distributed continuous variables, were 
calculated. Associations between the STI grade and mortality, complications and 30-day 
readmission were assessed using Pearson’s chi-square test and univariate logistic regression. 
To examine associations between grade and hospital and ICU lengths of stay and LRINEC 
scores, ANOVA and Tukey-adjusted post-hoc pairwise comparisons of means were used.
Multivariable mixed-effect logistic regression was used to assess the relationship between 
STI grade and the composite complication outcome, readmission, death, and any 
complication. Similarly, Poisson regression was used to measure the association between 
grade and hospital and ICU lengths of stay. These models were adjusted for potential 
confounding factors selected a priori: age, gender, insurance status, admission Glasgow 
Coma Scale score (GCS), admission mean arterial pressure (MAP), total number of beds in 
the admitting hospital, hospital status (academic or non-teaching), urban or rural location, 
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trauma center status and annual trauma center volume. Robust variance estimates were used 
to account for possible correlation of observations within centers.
Inter-rater reliability of grade assignment was assessed using the kappa coefficient and 
Cronbach’s alpha.7 Data were reported as the mean ± standard deviation except where 
specified otherwise and set the alpha at 0.05 for all tests. Results are reported for the logistic 
regression analyses as the adjusted odds ratios for each AAST grade, relative to Grade I, and 
those of the Poisson regression analyses as incidence rate ratios (IRR) relative to Grade I, 
together with their respective 95% confidence intervals (95% CI). 95% confidence intervals 
were computed for the kappa statistics using bootstrapping methods with 1000 replications. 
Stata SE version 14.2 was used for these analyses.
Results
12 centers contributed data for this study. 75% of centers were considered academic, 
compared to 25% non-teaching hospitals. 75% were located in urban centers, 8% were 
suburban, 8% were considered rural and 9% were other. Academic centers had a mean of 13 
surgeons (± 5.6) and 878 beds (± 570). Non-teaching hospitals had a mean of 9 surgeons 
(± 2) on staff and 372 beds (± 218). There were no statistical differences between groups.
1170 patients were included in this study. The mean age was 53 years (± 18.7) and 62% of 
the patients were male. 54.5% of patients were Caucasian, 17% were African-American, 
10.5% were Hispanic and 0.3% were of Asian descent. 16.8% of patients had private 
insurance, 57% had Medicare/Medicaid, 14.7% had no insurance and 11.6% had an other 
form of insurance(Table 1). Overall, 69.7% were seen by a surgeon during their admission 
and 60.4% required an operative intervention. Overall mortality was 1.7%
Patients were sub-classified based upon their EGS STI grade. 312 patients were included in 
Group 1, 117 in Group 2, 287 in Group 3, 181 in Group 4 and 243 in Group 5. In all groups, 
there were significantly more males, more Caucasians and more patients funded by 
Medicare/Medicaid (Table 1). Increasing severity of disease was also significantly 
associated with higher LRINEC scores, higher incidence of surgical consult and total 
number of operative cases, longer ICU and hospital length of stay, as well as a higher 
incidence of mortality (Tables 1&2).
Unadjusted outcomes for STI are demonstrated in Table 2. There was a significant 
association with increased need for vasopressors with increasing STI grade. Increasing STI 
grade was also significantly associated with recurrent infection at the initial STI site, 
increased general complications (including pneumonia, myocardial infarction, stroke and 
urinary tract infection), ICU and hospital length of stay, discharge to locations other than 
home and mortality. There was no significant association with 30 day readmission.
Multivariable analysis was used to assess outcomes as well. A ‘composite complication’ 
outcome was created and included both medical and surgical complications (see Appendix 
1). Compared to STI Grade I patients, patients with Grade IV and V disease had a 
significantly increased incidence of all complications (NSTI Grade I referent; Grade II OR 
1.38 (95% CI 0.68, 2.53); Grade III OR 0.789 (95% CI 0.44, 1.41); Grade IV OR 2.13 (95% 
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CI 1.22, 3.71); Grade V OR 2.41 (95% CI 1.42, 4.08)). There was no association between 
STI grade and the need for readmission within 30 days however (Grade II OR 1.69 (95% CI 
0.89, 3.17); Grade III OR 1.04 (95% CI 0.49, 2.20); Grade IV OR 0.65 (95% CI 0.31, 1.38); 
Grade V OR 1.51 (95% CI 0.86, 2.67)) (Table 3).
Infusion of vasopressor agents to support blood pressure in affected patients was 
significantly associated with higher grade STI’s (Grade II OR 2.72 (95% CI 0.89, 8.29); 
Grade III OR 1.38 (95% CI 0.18, 10.68); Grade IV OR 11.4 (95% CI 2.82, 46.16); Grade V 
OR 8.68 (95% CI 2.41, 31.30)). Increasing STI grade was also directly related to both 
intensive care unit length of stay (Grade II OR 2.78 (95% CI 2.06, 3.75); Grade III OR 1.64 
(95% CI 1.23, 2.19); Grade IV OR 7.98 (95% CI 6.32, 10.09); Grade V OR 9.78 (95% CI 
7.77, 12.31) and overall hospital length of stay (Grade II OR 1.47 (95% CI 1.34, 1.62); 
Grade III OR 1.33 (95% CI 1.23, 1.43); Grade IV OR 2.89 (95% CI 2.69, 3.10); Grade V 
OR 3.4 (95% CI 3.18, 3.63)). There was a bimodal peak in the risk of mortality, with a 
significant increase in mortality risk seen in patients with STI grades II and V disease 
(Grade II OR 5.34 (95% CI 1.21, 23.50); Grade III OR 0.66 (95% CI 0.07, 6.38); Grade IV 
OR 2.65 (95% CI 0.61, 11.43); Grade V OR 15.18 (95% CI 3.24, 71.12)) (Table 3).
Overall inter-rater reliability demonstrated a κ score of 0.668 (95% CI 0.624, 0.709, 74.2% 
concordance rate). Inter-rater reliability was also assessed for each of the four components 
of the STI score. Substantial inter-rater reliability was seen with grading of the operative 
component (κ score 0.642 (95% CI 0.571, 0.712), 76% concordance rate). The remaining 
three categories demonstrated moderate inter-rater reliability (clinical κ score 0.579 (95% CI 
0.529, 0.625), 69% concordance; radiologic κ score 0.577 (95% CI 0.495, 0.661), 68% 
concordance; pathologic κ score 0.472 (95% CI 0.374, 0.568), 64% concordance).
Discussion
Since the inception of the EGS grading scale project, scales for over 20 conditions have been 
defined and published.4, 8 Validation of the grading scales has been underway since the 
earliest scales were available. The first validation study, a multicenter study, demonstrated 
good correlation between increasing severity of disease and patient outcomes.5-6 Subsequent 
single institution studies have evaluated the validity of the EGS grading scales for acute 
appendicitis, acute cholecystitis and acute pancreatitis. In each of these studies, the EGS 
grading scale was found to be associated with outcomes. 9-11
Though the EGS grading scale has been validated for a variety of different diseases, this 
study fills an important niche. In general, the EGS grading scales are specifically designed to 
address two main gaps. On the one hand, care of the complex EGS patient is becoming 
increasingly fragmented. As patients are transferred between, and handed-off within, 
institutions, a common language to communicate the anatomic severity of disease is helpful. 
Additionally, many centers are beginning to construct EGS data registries. A valid, reliable 
anatomic scoring system is necessary to classify severity of disease, allowing for improved 
benchmarking of quality of care and more accurate research on these diseases.
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The current study focuses specifically on STIs. Necrotizing STIs (NSTIs) are uncommon, 
occurring in approximately 0.4/100,000 person-years and many surgeons may not see a true 
NSTI in their career.12-15 Validating the accuracy of the grading scale for a disease process 
such as this is therefore especially important. Further, NSTIs have a high associated 
mortality, allowing validation of the grading scale’s ability to predict mortality across the 
spectrum of disease severity. Most other studies evaluating the validity of the AAST EGS 
grading scales have not had sufficient power to identify associations between grade and 
mortality, partly as many of the diseases studied to date have had a low mortality rate.14, 16
The multicenter aspect of this study—with 1170 patients from 12 centers—allowed 
validation of the scale across a variety of institutions, practitioners, and patients. Because 
NSTIs (Grade IV and V disease) are rare compared to cellulitis and subcutaneous infections 
(Grade I and II disease) and abscess (Grade III disease), truly random sampling would result 
in a preponderance of low severity cases and little representation of more advanced STIs. To 
address this issue, we purposefully weighted our sampling scheme to allow a more equal 
distribution of patients from all five grades. This design allowed us to evaluate the 
association of grades with outcomes across the spectrum of STI severity.
The STI grading scale was also compared to the existing predictive tool for STI, the 
LRINEC score.17-19 The LRINEC score incorporates physiologic data present at admission 
including white blood cell count, hemoglobin, serum glucose, serum sodium, serum 
creatinine and C-reactive protein. A score of greater than or equal to 6 is associated with a 
high risk of necrotizing infection. LRINEC scores were also calculated for all patients 
included in the study. The median LRINEC score for the most severe STI’s in this study, a 
median of 4 for grade 4 and 5 disease, was notably lower than the usual predictive threshold 
of 6 for LRINEC. Some debate exists in the literature regarding the sensitivity of the 
LRINEC score, though it remains the most widely used predictive model.20-23 Increasing 
AAST EGS grades were associated with increasing LRINEC scores, despite the difference 
in predictive threshold.20-23 Further refinement of the EGS grading scales may ultimately 
result in greater alignment with existing predictive models or potentially prove superior.
Specific data regarding patient-related complications were recorded (Appendix 1). Due to 
the large variety of complications, we used a composite ‘complication’ outcome. High-grade 
STIs (grade IV and V) were associated with the composite complications. We also assessed 
the association between STI grade and the need for vasopressor support. Not surprisingly, a 
significant association was observed for vasopressor support. By inference, the STI grading 
scale may thus be associated with hemodynamic instability and the physiologic status of the 
patient. Finally, STI grades were also associated with increased ICU and hospital lengths of 
stay.
The association between STI grade and mortality was not entirely linear. In general, despite 
the severity of the disease process, mortality was low at 1.7%. There were two peaks seen 
for mortality. The 15-fold increase in mortality related to Grade V disease likely represents 
an accurate association between disease severity and risk of death. However, when 
translating the STI scales, Grade I and II disease represent mild to severe cellulitis. The 5-
fold increased risk of mortality associated with Grade II STIs (relative to Grade I) may be 
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attributable to confounding comorbid conditions or it may reflect that even superficial 
necrotizing infections truly do increase mortality.
An additional purpose of this validation study was to evaluate the reliability of grading 
between different graders. The grading scale includes criteria for clinical, radiologic, 
operative and pathologic findings from which we derived a maximum score. There was 
substantial reliability when determining an overall grade. We observed the greatest inter-
rater agreement with the operative score but less with the other criteria. These findings are 
similar to those observed in the previous multicenter validation study and indicate that the 
grades appear to be fairly reliable across providers, at disparate centers.6
After validating, the grading scales across a variety of disease processes in both single and 
multicenter formats, the EGS grading scales in general appear to be predictive of patient 
outcomes, are easy to use and are reliable between graders. In the future, early adopters of 
these scales for patient care and research should educate the larger community regarding the 
utility of the grading scales and promulgate their use. In particular, the importance of these 
data for registries cannot be overstated, as they will form the basis for a multitude of studies, 
especially in relation to relatively rare disease processes like NSTI. A further goal for the 
grading scales may be ongoing refinements, as needed, for particular disease processes. 
Such a refinement is underway in regards to grading acute cholecystitis with incorporation 
of a real-time, intra-operative component.11 Specifically in regards to STI, inclusion of 
physiologic parameters at the time of admission, perhaps in the form of the LRINEC score, 
as well as comorbid data will likely strengthen this scale.
One important limitation of the EGS grading scale is that some information pertinent to 
assessing the grade, such as operative findings or pathology, are available only after 
treatment of the patient, largely limiting the grading to a retrospective role. Greater emphasis 
should be placed on determining grades early in the patient’s course (e.g., based only on 
initial physical exam and radiographic criteria), so that they have greater utility in 
influencing management decisions. Further, the grading scales do not incorporate any 
physiologic data or information on patient comorbidities. This limitation was a choice 
consciously made by the grading scale authors, to keep the grading scales easy to remember 
and use. These characteristics clearly impact patient outcomes and must be collected 
separately for research purposes, however. These data only include patients admitted to the 
participating hospitals. Patients with mild forms of cellulitis, or small abscesses treated in 
clinics or the emergency room, would not be identified and are excluded from this analysis. 
Finally, EGS diseases run the spectrum from infectious to gastrointestinal to thoracic and 
beyond. One common scoring system, though easy to remember, may result in loss of 
specificity and gaps in data, which may be important for individual diseases. This issue must 
be addressed via a robust registry or further refinement of individual grading scales.
Conclusion
This multicenter study demonstrates the validity of the AAST STI grading scale. Higher 
disease grades were significantly associated with a number of important patient outcomes. 
Additionally, inter-rater reliability of the grading was moderate to substantial. Use of this 
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grading scale should be encouraged among those who care for STI patients, to improve 
communication between providers and allow better comparison of groups of patients with 
STIs for both research and quality measurement purposes. Future work will continue to 
refine some grading scales to better reflect specific characteristic of diseases and to address 
discrepancies in inter-rater reliability in use of the grading scale.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Flowchart demonstrate weighted patient sampling methods.
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Figure 2. 
The EGS Soft Tissue Infection grading scale.
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Table 1.
Patient characteristics stratified by STI grade
Grade I
(n=312)
Grade II
(n=117)
Grade III
(n=287)
Grade IV
(n=181)
Grade V
(n=243)
p-value
Age* (years) 52.1(SD 22.7)
54.9
(SD 19)
49.9
(SD 17.5)
54.4
(SD 14.6)
55.2
(SD 15.8)
0.0014
Gender
 % male
56.1% 59% 56.5% 68% 70.8% 0.0007
Race
Caucasian 55.8% 51.3% 54.7% 48.1% 56.8 0.0002
Afr. Amer. 13.8% 22.2% 14.6% 17.7% 21.4%
Hispanic 8.7% 6% 9.8% 11.6% 14.8%
Asian 0.6% 0.9% 0% 0% 0.4%
Other 21.2% 19.7% 20.9% 22.7% 6.6%
Insurance
 None 14.1% 12% 12.9% 12.7% 20.7% 0.0058
 Private 15.4% 17.1% 15.7% 15% 18.6%
 Medicare 57.4% 63.3% 64.1% 60.8% 45.5%
 Other 13.1% 7.7% 7.3% 11.6% 15.3%
LRINEC †
 score
2 (1, 4) 3 (1, 4) 3 (1, 4) 4 (3, 6) 4 (2, 6) <0.0001
*
mean (standard deviation)
†
median (interquartile range)
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Table 2.
Unadjusted outcomes by STI grade
Grade I
(n=312)
Grade II
(n=117)
Grade III
(n=287)
Grade IV
(n=181)
Grade V
(n=243)
p-value
Need for Pressors* 3 (1.0%) 5 (4.3%) 3 (1.1%) 32 (18.1%) 37 (15.6%) <0.0001
30 day Readmit* 36 (n=71) (50.1%) 16 (n=28) (57.1%) 29 (n=61) (47.5%) 18 (n=49) (36.7%) 34 (n=71) (47.9%) 0.4602
Recurrent Infection* 
(STI site)
39 (12.5%) 12 (10.3%) 32 (11.2%) 20 (11.1%) 49 (20.2%) 0.0115
General comp. ‡* 12 (3.9%) 4 (3.4%) 7 (2.4%) 13 (7.2%) 18 (7.4%) 0.0315
Surgical Consult† 28.5% 66.7% 79.4% 96.7% 96.3% <0.0001
Total No. Surgeries† 0 (0, 0) 0 (0, 1) 1 (1, 1) 2 (1, 3) 2 (1, 4) <0.0001
ICU days† 0 (0, 0) 0 (0, 0) 0 (0, 0) 0 (0, 6) 0 (0, 4) <0.0001
Inpatient days 3 (1, 6) 6 (3, 10.5) 4 (2, 8) 13 (7, 23) 14 (7, 23) <0.0001
Discharge
 Home 81% 79% 86% 58% 50% <0.0001
 SNF/rehab 17% 21% 13% 42% 48%
 Other 2% 0% 0.7% 0% 2.4%
Mortality % died 0.64% 3.42% 0.35% 4.97% 11.93% <0.0001
‡General complications include myocardial infarction, pneumonia, stroke and urinary tract infection.
*
absolute number (total percent)
†
median (interquartile range)
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Table 3.
Adjusted Outcomes by EGS STI Subgroup
Odds/Incidence Rate Ratio (95% CI)
Composite Complications
 Grade I -ref-
 Grade II 1.38 (0.68, 2.53)
 Grade III 0.79 (0.44, 1.41)
 Grade IV 2.13 (1.22, 3.71)
 Grade V 2.41 (1.42, 4.08)
Vasopressor Use
 Grade I -ref-
 Grade II 2.72 (0.89, 8.29)
 Grade III 1.38 (0.18, 10.7)
 Grade IV 11.4 (2.82, 46.2)
 Grade V 8.68 (2.41, 31.3
ICU Length of Stay
 Grade I -ref-
 Grade II 2.78 (2.06, 3.75
 Grade III 1.64 (1.23, 2.19)
 Grade IV 7.98 (6.32, 10.1)
 Grade V 9.78 (7.77, 12.3)
Hospital Length of Stay
 Grade I -ref-
 Grade II 1.47 (1.34, 1.62)
 Grade III 1.33 (1.23, 1.43)
 Grade IV 2.89 (2.69, 3.10)
 Grade V 3.40 (3.18, 3.63)
30-day Readmission
 Grade I -ref-
 Grade II 1.69 (0.89, 3.17)
 Grade III 1.04 (0.49, 2.20)
 Grade IV 0.65 (0.31, 1.38)
 Grade V 1.51 (0.86, 2.67)
Mortality
 Grade I -ref-
 Grade II 5.34 (1.21, 23.5)
 Grade III 0.66 (0.07, 6.38)
 Grade IV 2.65 (0.61, 11.4)
 Grade V 15.2 (3.24, 71.1)
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